EFFECT OF INTRANASAL GLUCAGON ON BLOOD GLUCOSE LEVELS IN HEALTHY SUBJECTS AND HYPOGLYCAEMIC PATIENTS WITH INSULIN-DEPENDENT DIABETES
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Glucagon in solution with a surfactant (deoxycholic acid 1% w/v) was administered by intranasal spray to 6 healthy fasting subjects and 6 insulin-dependent diabetics with insulin-induced hypoglycaemia. In the normal subjects, intranasal glucagon increased plasma glucose levels, with a dose-response effect. In the diabetic patients, plasma glucose levels showed a mean increase of 100% above nadir values in approximately 26 min in response to 7.5 mg intranasal glucagon; hypoglycaemic symptoms were relieved within about 7 min. These results suggest that intranasal glucagon is effective and may represent an alternative to parenteral glucagon or glucose or to oral sugar as the first-line treatment of hypoglycaemic episodes in insulin-dependent diabetics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, glucagon drives hepatic and renal gluconeogenesis to increase endogenous blood glucose levels9 during prolonged fasting.”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [9]
Citations
Cites
Bolli, G., Feo, P. D., Compagnucci, P., Cartechini, M. G., Angeletti, G., Santeusanio, F., Brunetti, P., & Gerich, J. E. (1983) · Diabetes · doi:10.2337/diab.32.2.134 · Cited by 433
Moses, A. C., Gordon, G. S., Carey, M. C., & Flier, J. S. (1983) · Diabetes · doi:10.2337/diab.32.11.1040 · Cited by 206
Abnormal Glucose Counterregulation after Subcutaneous Insulin in Insulin-Dependent Diabetes Mellitus
Bolli, G. B., Dimitriadis, G. D., Pehling, G. B., Baker, B. A., Haymond, M. W., Cryer, P. E., & Gerich, J. E. (1984) · New England Journal of Medicine · doi:10.1056/nejm198406283102605 · Cited by 167
More on Neuropathy from Pyridoxine Abuse
Berger, A., & Schaumburg, H. H. (1984) · New England Journal of Medicine · doi:10.1056/nejm198410113111513 · Cited by 127
Collier, A., Steedman, D. J., Patrick, A. W., Nimmo, G. R., Matthews, D. M., Macintyre, C. C. A., Little, K., & Clarke, B. F. (1987) · Diabetes Care · doi:10.2337/diacare.10.6.712 · Cited by 71
Glucagon Treatment of Insulin Reactions
Elrick, H., Witten, T. A., & Arai, Y. (1958) · New England Journal of Medicine · doi:10.1056/nejm195803062581005 · Cited by 55
Glucagon: hormone or therapeutic agent?
Hall-Boyer, K., Zaloga, G. P., & Chernow, B. (1984) · PubMed · Cited by 49
Pontiroli, A. E., Alberetto, M., & Pozza, G. (1985) · Acta Diabetologica · doi:10.1007/bf02590783 · Cited by 36
PREPRANDIAL INTRANASAL INSULIN AS ADJUVANT THERAPY IN TYPE II DIABETICS
El‐Etr, M., Slama, G., & Desplanque, N. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91508-x · Cited by 13
Glucagon as a Counterregulatory Hormone
Gerich, J. E. (1983) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69019-8_15 · Cited by 6
Cited by
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Glucagon and regulation of glucose metabolism
Jiang, G., & Zhang, B. B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00492.2002 · Cited by 905
“Administration of exogenous glucagon increases glucose levels in fasted or fed animals (63, 96), and similar observations were made in humans (29, 42, 57).”
BackgroundResultIntranasal delivery: Physicochemical and therapeutic aspects
Costantino, H. R., Illum, L., Brandt, G., Johnson, P. H., & Quay, S. C. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.025 · Cited by 598
Emerging Roles of Vascular Endothelium in Metabolic Homeostasis
Pi, X., Xie, L., & Patterson, C. (2018) · Circulation Research · doi:10.1161/circresaha.118.313237 · Cited by 296
“activity, glucagon secreted from pancreatic alpha cells activates glycogenolysis and gluconeogenesis signaling pathways in the liver to increase glucose production.(18) FFAs stored as TG in adipose tissue can also be mobilized through lipolysis and used by peripheral tissues, which is stimulated by glucagon and adrena…”
BackgroundGowd, V., Jia, Z., & Chen, W. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.07.015 · Cited by 239
Metadata
- Authors
- FREYCHET, L.
- Affiliations
- Hôtel-Dieu de Paris (FR)
- Corresponding author
- FREYCHET, L
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1988-06
- Volume
- 331
- Issue
- 8599
- Pages
- 1364-1366
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2046048588
- Cited by
- 67
- References
- 10
- Citations by year
- 2025: 1 · 2024: 5 · 2023: 2 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 4 · 2016: 4 · 2015: 3 · 2014: 4 · 2013: 2 · 2012: 2
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 1 diabetes, hypoglycemia, plasma glucose, deoxycholic acid, surfactants, dose-response relationship
- MeSH terms
- Administration, Intranasal, Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 1, Evaluation Studies as Topic, Female, Glucagon, Humans, Hypoglycemia, Insulin, Male, Radioimmunoassay
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: EFFECT OF INTRANASAL GLUCAGON ON BLOOD GLUCOSE LEVELS IN HEALTHY SUBJECTS AND HYPOGLYCAEMIC PATIENTS WITH INSULIN-DEPENDENT DIABETES. https://app.cochat.ai/papers/10.1016/s0140-6736(88)92181-2
- The paper
- FREYCHET, L. (1988). EFFECT OF INTRANASAL GLUCAGON ON BLOOD GLUCOSE LEVELS IN HEALTHY SUBJECTS AND HYPOGLYCAEMIC PATIENTS WITH INSULIN-DEPENDENT DIABETES. The Lancet. https://doi.org/10.1016/s0140-6736(88)92181-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.